NCT05802628

Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets

A Single-arm, Open-label Study to Explore the Salivary Concentration of Cetylpyridinium Chloride Buccal Tablets After Single-dose Administration in Healthy Subjects

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Peking University People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The study is a single-arm, open-label study to explore the salivary concentration of Cetylpyridinium Chloride Buccal Tablets after single-dose administration in Healthy Subjects

Detailed description

Primary Objective: To observe the concentration of the investigational product in the saliva of healthy subjects. Secondary purpose: To observe the safety of the investigational product in healthy subjects.

Conditions

• Pharyngitis Acute
• Gingivitis

Interventions

Type	Name	Description
DRUG	Cetylpyridinium Chloride Buccal Tablets	Subjects administrated single dose of Cetylpyridinium Chloride Buccal Tablet

Timeline

• Start date: 2023-04-10
• Primary completion: 2023-04-18
• Completion: 2023-04-18
• First posted: 2023-04-06
• Last updated: 2023-07-12

Locations

1 site across 1 country: China